Angarita GA, Matuskey D, Pittman B, Costeines JL, Potenza MN, Jastreboff AM, et al
A 2025 systematic review by Sarkar, Yadav, and colleagues in the International Journal of Dermatology analyzed evidence across topical (0.1-2%), oral (250-500 mg/day), and intravenous routes including five oral RCTs and additional topical and IV studies and characterized topical and oral glutathione as moderately effective (with topical 0.5% superior to lower concentrations and combined topical-plus-oral outperforming monotherapy) while explicitly flagging intravenous glutathione as contraindicated due to lack of efficacy and adverse side effects, citing a single placebo-controlled IV study in which 37.5% (6/16) of the treatment group versus 18.7% (3/16) of the placebo group achieved the endpoint (p = 0.054, not statistically significant)
For deeper pigmentation concerns, dermatologists often combine glutathione with laser or peel treatments for stronger results
The peptide reconstitution calculator ensures accurate mixing
Physical therapy addresses the movement patterns, strength imbalances, and mobility restrictions that contribute to these injuries
A note: Andel is currently operational in New York State